GSK
p1,399.50
▲+1.60%
Stock
Glaxosmithkline Plc Ord 25P
Official Company Name: GlaxoSmithKline plc
Stock Symbol: GSK
Stock Market: London Stock Exchange - LSE
Currency: Penny sterling - GBX
GSK - Stock Indices
GSK Stock Price - 1 Year Price Evolution & Moving Averages
1 Year Return
▼-22.68%
Daily closing prices, with moving averages and volumes - Penny sterling (GBX)
Moving averages:
- — EMA20
- — SMA50
- — SMA200
GlaxoSmithKline plc Categories
United Kingdom
languages
Healthcare
languages
Drug Manufacturers—General
Healthcare
Drug Manufacturers—General
Company Description
GlaxoSmithKline PLC, better known as GSK, is a pharmaceutical company. GSK manufactures products for major disease areas such as asthma, cancer, infections, diabetes, and mental health, and it also has a portfolio of vaccines. Operating in more than 115 countries, GSK is also engaged in the consumer healthcare business in oral health, pain relief, respiratory, nutrition/gastro-intestinal, and skin health categories.
GSK Stock Data
| Open | p1,340.00 |
| High | p1,405.50 |
| Low | p1,328.50 |
| Close | p1,399.50 |
| Volume | 10,819,874 |
| Previous Close | p1,377.50 |
| 1-Day Change | 22.00 |
| 1-Year Change | -410.50 |
| Average Daily Volume | 8,538,206 |
| 52-Week High | p1,812.50 |
| 52-Week Low | p1,264.00 |
Ratios as of Jan. 25, 2025
| Beta | 0.33 |
| Trailing PE | 22.19 |
| Forward PE | 8.06 |
Unlock Financial AI: get advanced tools and data with a free trial of Disfold AI
Disclaimer
All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!
Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.
Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).
Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.
Please conduct your own due diligence to verify insights.